Abciximab: An Updated Review of its Therapeutic Use in Patients with Ischaemic Heart Disease Undergoing Percutaneous Coronary Revascularisation

By Ibbotson T.   McGavin J.K.   Goa K.L.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1121-1163

Adis International

Access to resources Recommend Favorite

The Influence of Complete Coronary Revascularization on Long-term Outcomes in Patients with Multivessel Coronary Heart Disease Undergoing Successful Percutaneous Coronary Intervention

By Yang HH   Chen Y   Gao CY  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1106-1112

Field House Publishing

Access to resources Recommend Favorite

Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Observational Registry Study

By Iversen Allan Z.   Galatius Soeren   Pedersen Sune   Madsen Jan K.   Jensen Jan S.  

Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. : 369-378

Adis International

Access to resources Recommend Favorite

Association between Abciximab and Length of Stay in Intensive Care for Patients Undergoing Percutaneous Coronary Intervention: A 2-Stage Econometric Model in a Naturalistic Setting

By Lage M.J.  

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 581-589

Adis International

Access to resources Recommend Favorite

Medical Treatment of Patients with Heart Failure or Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention

By Lipinski Michael J.   Vetrovec George W.  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 313-325

Adis International

Access to resources Recommend Favorite